English(EN) AI/ML studies grow on ClinicalTrials.gov (2010-2023) 📊 3,106 studies, only 7.6% FDA-regulated # AI # ML # ClinicalTrials # FDA # HealthDisparities https:// tnyp

AI/ML研究在ClinicalTrials.gov上激增，FDA监管有限

作者 PulseAugur 编辑部 · [1 个来源] · 2026-06-22 12:21

对2010年至2023年ClinicalTrials.gov上研究的回顾显示，AI/ML研究显著增加。在3,106项研究中，只有7.6%受到FDA监管，这凸显了医疗保健领域AI应用监管的不足。 AI

影响表明AI/ML在医疗保健研究中的采用趋势日益增长，可能对监管框架产生影响。

排序理由对AI/ML研究中的研究趋势和监管审查的分析。[lever_c_demoted from research: ic=1 ai=0.7]

在 Mastodon — fosstodon.org 阅读 →

AI 生成摘要 · Google Gemini · 来自 1 个来源。我们如何撰写摘要 →

本文如何被排名

Signal score: 0 / 100; Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket: Tool; 对AI/ML研究中的研究趋势和监管审查的分析。[lever_c_demoted from research: ic=1 ai=0.7]
Source corroboration: Single-source cluster; Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics: product, policy; Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance: High; Clearly on-topic for AI-industry coverage.
Story freshness: 99 days old; Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

完整方法见我们的编辑标准。

报道来源 [1]

Mastodon — fosstodon.org TIER_1 English(EN) · [email protected] · 2026-06-22 12:21

ClinicalTrials.gov 上人工智能/机器学习研究数量增长 (2010-2023) 📊 3,106 项研究，仅 7.6% 受 FDA 监管 #AI #ML #ClinicalTrials #FDA #HealthDisparities https://tnyp

AI/ML studies grow on ClinicalTrials.gov (2010-2023) 📊 3,106 studies, only 7.6% FDA-regulated # AI # ML # ClinicalTrials # FDA # HealthDisparities https:// tnyp.me/jG1jMhnS/m🙂

链接 jmir.org/…/e57750

本文如何被排名

报道来源 [1]

ClinicalTrials.gov 上人工智能/机器学习研究数量增长 (2010-2023) 📊 3,106 项研究，仅 7.6% 受 FDA 监管 #AI #ML #ClinicalTrials #FDA #HealthDisparities https://tnyp

相关实体

相关话题